HRME: Screening for Cervical Cancer and Its Precursors in Low-Resource Settings
NCT02494310 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2017-02-03
Summary
A new mobile diagnostic and treatment unit is being developed by BCH to address the loss-to follow-up associated with the mobile screening program and demonstrate POC diagnosis by HRME. The mobile diagnostic and treatment unit will be equipped with the tools and infrastructure necessary to perform HRME, VIA, colposcopy, biopsy and treatment with cryotherapy. A team of a colposcopist, nurse, nursing assistant, and driver will staff the mobile diagnostic and treatment unit. The unit will travel to offer follow-up diagnostic and treatment services to women who have screened positive during a prior visit with the mobile screening unit. The mobile diagnostic and treatment unit will be constructed and maintained at BCH.
Conditions
- Neoplasia of the Uterine Cervix
- Cancer Prevention
- Cervical Intraepithelial Neoplasia
Interventions
- DEVICE
-
High-Resolution Microendoscopy Imaging
Innovative technique to evaluate epithelial cell morphology in situ. The device is not invasive and does not exchange energy with human body.
Sponsors & Collaborators
-
William Marsh Rice University
collaborator OTHER -
M.D. Anderson Cancer Center
collaborator OTHER -
National Institutes of Health (NIH)
collaborator NIH -
Barretos Cancer Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-01
- Primary Completion
- 2016-08-31
- Completion
- 2016-12-31
More Related Trials
-
iMproving thE DIagnostics And Treatment Of ceRvical Precancer
NCT05870787 ·Status: COMPLETED
-
Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix
NCT02206048 ·Status: COMPLETED ·Phase: NA
-
Combined Digital Colposcopy Analysis to Improve Cervical Precancer and Cancer Detection
NCT01094132 ·Status: COMPLETED ·Phase: PHASE2
-
A Novel, Low-Cost, Handheld 3D Imaging System for Improved Screening for Cervical Neoplasia in Resource-Limited Settings
NCT06810427 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Randomized Study to Compare a Hydrogel Packing System to Standard Packing During HDR Brachytherapy for Cervical Cancer
NCT04499521 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care
NCT06850402 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Point-of-Care Ultraviolet Microscopy for Cervical Cancer Screening
NCT05899647 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Rice Technologies for Cervical Cancer Screening and Diagnosis
NCT05372484 ·Status: RECRUITING ·Phase: NA
-
Molecular Imaging for Detection of Cervical Intraepithelial Neoplasia
NCT00511615 ·Status: COMPLETED
-
Primary HPV-based Cervical Cancer Screening Algorithms in Botswana
NCT04242823 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology
NCT07244315 ·Status: COMPLETED
-
Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence
NCT00682552 ·Status: TERMINATED ·Phase: NA
-
The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection
NCT03366493 ·Status: UNKNOWN ·Phase: PHASE3
-
Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer
NCT06815939 ·Status: RECRUITING ·Phase: NA
-
OCT-AF Imaging of Pre-cancers of Vulva and Cervix
NCT03285841 ·Status: TERMINATED
-
Emergency Department-based Cervical Cancer Screening Through Self-sampling
NCT07345897 ·Status: RECRUITING ·Phase: NA
-
Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy
NCT07214584 ·Status: RECRUITING
-
Reflectance Confocal Imaging in Cervical Cancer Patients
NCT00505726 ·Status: COMPLETED
-
New Modalities for Detection of Oropharyngeal Cancer
NCT03226613 ·Status: COMPLETED ·Phase: NA
-
Radiation Therapy Planning by Multi-parametric PET/MRI Imaging in Patients With Cervical Cancer
NCT03655977 ·Status: UNKNOWN ·Phase: NA
-
Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings - Optimization Phase
NCT04905134 ·Status: COMPLETED ·Phase: NA
-
A Non-inferiority Evaluation of a Smart-phone Based Cervical Imaging Device.
NCT05388162 ·Status: COMPLETED ·Phase: NA
-
Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia
NCT04274465 ·Status: COMPLETED
-
Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment
NCT04743674 ·Status: RECRUITING
-
HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix
NCT04333212 ·Status: COMPLETED ·Phase: NA